The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
α-blocker-Global Market Insights and Sales Trends 2025
Synopsis
α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
The global α-blocker market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of α-blocker in various end use industries. The expanding demands from the Hypertension, Raynaud's Disease and Erectile Dysfunction,, are propelling α-blocker market. Non-selective Antagonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Antagonists segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for α-blocker market, driven by demand from China, the second largest economy with some signs of stabilising, the α-blocker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for α-blocker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global α-blocker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global α-blocker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, α-blocker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of α-blocker covered in this report include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc.
The global α-blocker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Global α-blocker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global α-blocker market, Segment by Type:
Non-selective Antagonists
Selective Antagonists
Global α-blocker market, by Application
Hypertension
Raynaud's Disease
Erectile Dysfunction
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of α-blocker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of α-blocker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
The global α-blocker market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of α-blocker in various end use industries. The expanding demands from the Hypertension, Raynaud's Disease and Erectile Dysfunction,, are propelling α-blocker market. Non-selective Antagonists, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Antagonists segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for α-blocker market, driven by demand from China, the second largest economy with some signs of stabilising, the α-blocker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for α-blocker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global α-blocker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global α-blocker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, α-blocker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of α-blocker covered in this report include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc.
The global α-blocker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Global α-blocker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global α-blocker market, Segment by Type:
Non-selective Antagonists
Selective Antagonists
Global α-blocker market, by Application
Hypertension
Raynaud's Disease
Erectile Dysfunction
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of α-blocker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of α-blocker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 α-blocker Market Overview
1.1 α-blocker Product Overview
1.2 α-blocker Market Segment by Type
1.2.1 Non-selective Antagonists
1.2.2 Selective Antagonists
1.3 Global α-blocker Market Size by Type
1.3.1 Global α-blocker Market Size Overview by Type (2018-2029)
1.3.2 Global α-blocker Historic Market Size Review by Type (2018-2023)
1.3.3 Global α-blocker Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America α-blocker Sales Breakdown by Type (2018-2023)
1.4.2 Europe α-blocker Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific α-blocker Sales Breakdown by Type (2018-2023)
1.4.4 Latin America α-blocker Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa α-blocker Sales Breakdown by Type (2018-2023)
2 Global α-blocker Market Competition by Company
2.1 Global Top Players by α-blocker Sales (2018-2023)
2.2 Global Top Players by α-blocker Revenue (2018-2023)
2.3 Global Top Players by α-blocker Price (2018-2023)
2.4 Global Top Manufacturers α-blocker Manufacturing Base Distribution, Sales Area, Product Type
2.5 α-blocker Market Competitive Situation and Trends
2.5.1 α-blocker Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by α-blocker Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in α-blocker as of 2022)
2.7 Date of Key Manufacturers Enter into α-blocker Market
2.8 Key Manufacturers α-blocker Product Offered
2.9 Mergers & Acquisitions, Expansion
3 α-blocker Status and Outlook by Region
3.1 Global α-blocker Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global α-blocker Historic Market Size by Region
3.2.1 Global α-blocker Sales in Volume by Region (2018-2023)
3.2.2 Global α-blocker Sales in Value by Region (2018-2023)
3.2.3 Global α-blocker Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global α-blocker Forecasted Market Size by Region
3.3.1 Global α-blocker Sales in Volume by Region (2024-2029)
3.3.2 Global α-blocker Sales in Value by Region (2024-2029)
3.3.3 Global α-blocker Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global α-blocker by Application
4.1 α-blocker Market Segment by Application
4.1.1 Hypertension
4.1.2 Raynaud's Disease
4.1.3 Erectile Dysfunction
4.2 Global α-blocker Market Size by Application
4.2.1 Global α-blocker Market Size Overview by Application (2018-2029)
4.2.2 Global α-blocker Historic Market Size Review by Application (2018-2023)
4.2.3 Global α-blocker Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America α-blocker Sales Breakdown by Application (2018-2023)
4.3.2 Europe α-blocker Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific α-blocker Sales Breakdown by Application (2018-2023)
4.3.4 Latin America α-blocker Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa α-blocker Sales Breakdown by Application (2018-2023)
5 North America α-blocker by Country
5.1 North America α-blocker Historic Market Size by Country
5.1.1 North America α-blocker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America α-blocker Sales in Volume by Country (2018-2023)
5.1.3 North America α-blocker Sales in Value by Country (2018-2023)
5.2 North America α-blocker Forecasted Market Size by Country
5.2.1 North America α-blocker Sales in Volume by Country (2024-2029)
5.2.2 North America α-blocker Sales in Value by Country (2024-2029)
6 Europe α-blocker by Country
6.1 Europe α-blocker Historic Market Size by Country
6.1.1 Europe α-blocker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe α-blocker Sales in Volume by Country (2018-2023)
6.1.3 Europe α-blocker Sales in Value by Country (2018-2023)
6.2 Europe α-blocker Forecasted Market Size by Country
6.2.1 Europe α-blocker Sales in Volume by Country (2024-2029)
6.2.2 Europe α-blocker Sales in Value by Country (2024-2029)
7 Asia-Pacific α-blocker by Region
7.1 Asia-Pacific α-blocker Historic Market Size by Region
7.1.1 Asia-Pacific α-blocker Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific α-blocker Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific α-blocker Sales in Value by Region (2018-2023)
7.2 Asia-Pacific α-blocker Forecasted Market Size by Region
7.2.1 Asia-Pacific α-blocker Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific α-blocker Sales in Value by Region (2024-2029)
8 Latin America α-blocker by Country
8.1 Latin America α-blocker Historic Market Size by Country
8.1.1 Latin America α-blocker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America α-blocker Sales in Volume by Country (2018-2023)
8.1.3 Latin America α-blocker Sales in Value by Country (2018-2023)
8.2 Latin America α-blocker Forecasted Market Size by Country
8.2.1 Latin America α-blocker Sales in Volume by Country (2024-2029)
8.2.2 Latin America α-blocker Sales in Value by Country (2024-2029)
9 Middle East and Africa α-blocker by Country
9.1 Middle East and Africa α-blocker Historic Market Size by Country
9.1.1 Middle East and Africa α-blocker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa α-blocker Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa α-blocker Sales in Value by Country (2018-2023)
9.2 Middle East and Africa α-blocker Forecasted Market Size by Country
9.2.1 Middle East and Africa α-blocker Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa α-blocker Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer α-blocker Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis α-blocker Products Offered
10.2.5 Novartis Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck α-blocker Products Offered
10.3.5 Merck Recent Development
10.4 Astra Zeneca
10.4.1 Astra Zeneca Company Information
10.4.2 Astra Zeneca Introduction and Business Overview
10.4.3 Astra Zeneca α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Astra Zeneca α-blocker Products Offered
10.4.5 Astra Zeneca Recent Development
10.5 Jhonson and Johnson
10.5.1 Jhonson and Johnson Company Information
10.5.2 Jhonson and Johnson Introduction and Business Overview
10.5.3 Jhonson and Johnson α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Jhonson and Johnson α-blocker Products Offered
10.5.5 Jhonson and Johnson Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Eli Lilly α-blocker Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanofi α-blocker Products Offered
10.7.5 Sanofi Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bristol-Myers Squibb α-blocker Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer α-blocker Products Offered
10.9.5 Bayer Recent Development
10.10 GSK
10.10.1 GSK Company Information
10.10.2 GSK Introduction and Business Overview
10.10.3 GSK α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.10.4 GSK α-blocker Products Offered
10.10.5 GSK Recent Development
10.11 Teva Pharmaceutical
10.11.1 Teva Pharmaceutical Company Information
10.11.2 Teva Pharmaceutical Introduction and Business Overview
10.11.3 Teva Pharmaceutical α-blocker Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Teva Pharmaceutical α-blocker Products Offered
10.11.5 Teva Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 α-blocker Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 α-blocker Industrial Chain Analysis
11.4 α-blocker Market Dynamics
11.4.1 α-blocker Industry Trends
11.4.2 α-blocker Market Drivers
11.4.3 α-blocker Market Challenges
11.4.4 α-blocker Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 α-blocker Distributors
12.3 α-blocker Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
